Utility of vertebral left atrial size and vertebral heart size to aid detection of congestive heart failure in dogs with respiratory signs

Case report: Clinical fungal endocarditis as a component of presumptive systemic aspergillosis infection in a dog

A 2-year-old 26-kilogram female spayed mixed breed dog presented for acute azotemia, a new heart murmur, anorexia, and lethargy. Further workup revealed marked azotemia with bilateral renal changes on abdominal ultrasound. An echocardiogram detected vegetative lesion on the mitral valve, consistent with infective endocarditis. The patient tested positive for the galactomannan antigen (Aspergillus EIA Galactomannan Test by MiraVista) leading to a presumptive diagnosis of systemic aspergillosis. Despite aggressive treatment, the patient continued to deteriorate and developed signs of dyspnea which temporarily improved with furosemide therapy (VetOne; Boise, ID). After humane euthanasia, postmortem evaluation confirmed fungal endocarditis. This is the first published case of clinical endocarditis in a dog suspected to be from aspergillosis based on both antemortem diagnostics and postmortem pathology. Thus, this case serves to further our understanding of systemic aspergillosis manifestations which in turn can aid in prompt diagnosis and treatment of the condition.

Vertebral Heart Score and Vertebral Left Atrial Size as Radiographic Measurements for Cardiac Size in Dogs-A Literature Review

Radiology plays an important role in veterinary cardiology, along with other methods, such as electrocardiography, echocardiography, and biomarkers, in the diagnosis of cardiac diseases. Particularly, thoracic radiography is often used to assess heart size and for confirmation of left-sided congestive heart failure by the presence of pulmonary edema. Many cardiac diseases in dogs are associated with a heart size increase, especially in more advanced stages, and cardiac size assessment has been of great interest for a long time for both clinicians and researchers. A substantial number of methods for heart size measurement has been described; however, two methods, the vertebral heart score and the vertebral left atrial size are currently widely used in dogs. Therefore, the literature provides an abundant number of research articles for using these measurements in both healthy dogs and dogs with cardiac and extra-cardiac pathologic conditions. This review article aims to cover the current use of two radiographic measurements of the heart in healthy and diseased dogs, based on the available literature.

Transcatheter Edge-to-Edge Repair of the Mitral Valve in Four Dogs: Preliminary Results Regarding Efficacy and Safety

Mitral valve disease is a common heart disease in dogs. The aim of this study was to describe the cases of dogs that underwent mitral valve repair via a V-clamp device and to provide long-term follow-up data on cardiac function after mitral valve repair. Four dogs with mitral valve regurgitation who experienced coughing and dyspnea underwent surgical mitral valve repair between December 2023 and March 2024. The patients were evaluated via transthoracic and transesophageal echocardiography. Echocardiography revealed mitral valve leaflet regurgitation. Mitral valve repair was performed under general anesthesia using a V-clamp device introduced through an introducer wire guide. Echocardiography was conducted at baseline and during the six-month follow-up. Blood analysis results after surgical repair were normal. Follow-up echocardiography revealed no complications related to the procedure, with all dogs demonstrating improved respiratory signs and quality of life after repair. No adverse reactions were reported after surgery. A V-clamp device was used to repair mitral valve regurgitation in four dogs. Mitral valve repair via a V-clamp device is another treatment option for mitral valve disease in dogs.

Self-Reported Utilization of International (ACVIM Consensus) Guidelines and the Latest Clinical Trial Results on the Treatment of Dogs with Various Stages of Myxomatous Mitral Valve Degeneration: A Survey among Veterinary Practitioners

BACKGROUND

Myxomatous mitral valve degeneration is the most common canine heart disease. Several clinical trials have investigated various treatments. The latest recommendations are published in the ACVIM consensus guidelines (2019). Our study aimed to investigate how closely veterinary practitioners apply the treatment recommendations of these guidelines and the latest clinical trials.

METHODS

An online survey was sent to Dutch and Belgian veterinary practices via digital channels.

RESULTS

The data from 363 fully completed surveys were analyzed. For stage B1 disease, 93% recommended, correctly, no treatment. For stage B2 disease, 67% of the respondents recommended starting pimobendan as monotherapy. For chronic treatment of stage C disease, 16 different drug combinations were mentioned, but nobody recommended surgery. Only 48% of the respondents recommended the only evidence-based drug combination: a loop diuretic with pimobendan. A concerning finding was the simultaneous prescription of two loop diuretics, by 19% of the respondents.

CONCLUSIONS

Treatment recommendations showed an increasing variation with more advanced disease stages from B1 through B2 to C. This reflects the increasing disagreement among the panelists who prepared the ACVIM consensus guidelines. Practitioners of our study seem to practice more evidence-based medicine than veterinary cardiologists, as it was reported in a recent survey-based study.

Radiographic Left Atrial Size Measurement of Dogs in Different Mitral Valve Disease Stages with Four Different Methods

The left atrial size increases (LAS) in patients with mitral valve disease (MVD) as the disease progresses. The vertebral left atrial size (VLAS), the modified-vertebral left atrial size (M-VLAS), and the radiographic left atrial dimension (RLAD) are methods reported to assess LAS on dogs' radiographs. All these methods transform the LAS into vertebral units. The thoracic inlet (TI) has been used as a reliable reference point to measure the cardiac silhouette of dogs with MVD in different stages. The objective of this study was to assess the clinical utility of measuring a dog LAS on right thoracic X-rays using the TI as a reference and determine whether it could differentiate dogs in different MVD stages. LAS was divided by the TI to obtain the thoracic inlet left atrial score (TILAS). This was a retrospective observational study including 135 apparently healthy dogs performed to assess their LAS with four different methods: VLAS, M-VLAS, RLAD, and TILAS. Thirty-six dogs from the general population were selected and compared to 100 dogs in different MVD stages. The TILAS was significantly different between the control dogs and MVD dogs, increasing with the disease stage: control dogs 0.51 ± 0.08, B1 0.57 ± 0.14, B2 0.75 ± 0.13, and C 0.84 ± 0.18. VLAS, M-VLAS, and RLAD also increased as the disease progressed, as shown in previous studies. The TILAS accuracy to distinguish MVD dogs with cardiac enlargement was comparable to VLAS, M-VLAS, and RLAD (AUC 0.91 vs. 0.93, 0.90, and 0.94 respectively). A TILAS > 0.8 can identify dogs with cardiac enlargement secondary to MVD.